[ad_1]
Marathi actor Ketaki Chitale is not new to controversies. According to her Instagram bio, she is a motivational speaker and works for epilepsy awareness.
Actor Ketaki Chitale who was arrested for allegedly sharing a derogatory post on Facebook about Nationalist Congress Party chief Sharad Pawar has been sent to police custody till May 18 as she was produced before a court on Sunday. A total of five cases have been registered against the actor so far for sharing a post on Sharad Pawar’s appearance, illness and voice. The post contained disparaging comments on Sharad Pawar like “hell is waiting” and “you hate Brahmins”. Apart from the actor, a 23-year-old pharmacy student was also arrested in Maharashtra for tweeting something objectionable against Sharad Pawar.
Here are 5 things to know about actor Ketaki Chitale:
1. Ketaki Chitale is a 29-year-old film and television actor. She has worked in Star Pravah’s Ambat Goad, Zee5’s Tuza Maza Breakup, and Sony TV’s Saas Bina Sasural etc.
2. The actor’s Instagram bio says she is a motivational speaker.
3. The actor was diagnosed with epilepsy at a young age, according to one of her social media posts.
4. Ketaki Chitale is also the founder and CEO of Accept Epilepsy which, according to social media, helps epilepsy warriors in their everyday battle.
5. Ketaki Chitale is active on Facebook and Instagram and this is not the first controversial statement she has made.
Trending Topics to Follow
[ad_2]
Source link
Journalist Details
Latest entries
Brand StoriesMarch 7, 2026Career Story: How Vibhanshu Upadhyay Built a Professional Footprint in India’s Luxury Wedding Industry Latest NewsFebruary 25, 2026Tributes Pour In as Tamil Nadu Bids Farewell to CPI Veteran R. Nallakannu Brand StoriesFebruary 24, 2026From Vrindavan to the Punjabi Music Industry: Gaurangi (Gaura) and Krishna Mishra’s New Track ‘Yaar Jhutha E’ Set to be the Year’s Biggest Emotional Banger! Brand StoriesFebruary 21, 2026Bartr.in Goes National: India’s “Craigslist 3.0” Crosses 50,000+ Users in 7 Days, Secures ₹45 Lakh Grant, Eyes Series A

